Anika Therapeutics Inc
SWB:AKP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Anika Therapeutics Inc
SWB:AKP
|
US |
|
R
|
Resolute Mining Ltd
OTC:RMGGF
|
AU |
|
InvoCare Ltd
ASX:IVC
|
AU |
|
S
|
Sturm Ruger & Company Inc
XBER:ST2
|
US |
|
Chewy Inc
F:3HH
|
US |
|
Codan Ltd
ASX:CDA
|
AU |
|
Sensus Healthcare Inc
F:5TX
|
US |
Wall St Price Targets
AKP Price Targets Summary
Anika Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for AKP is 15.29 EUR with a low forecast of 14.7 EUR and a high forecast of 16.19 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AKP's stock price target?
Price Target
15.29
EUR
According to Wall Street analysts, the average 1-year price target for AKP is 15.29 EUR with a low forecast of 14.7 EUR and a high forecast of 16.19 EUR.
What is the Revenue forecast for Anika Therapeutics Inc?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 7%.
What is the Gross Profit forecast for Anika Therapeutics Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next 2 years is 6%.
